These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1900037

  • 1. Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression.
    Esumi N, Hunt B, Itaya T, Frost P.
    Cancer Res; 1991 Feb 15; 51(4):1185-9. PubMed ID: 1900037
    [Abstract] [Full Text] [Related]

  • 2. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW, Ananthaswamy HN.
    J Immunol; 1993 Jul 01; 151(1):244-55. PubMed ID: 8326126
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J, Moyana T.
    Cancer Gene Ther; 1998 Jul 01; 5(5):313-20. PubMed ID: 9824051
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2.
    Hiura M, Hashimura T, Watanabe Y, Kuribayashi K, Yoshida O.
    Folia Biol (Praha); 1994 Jul 01; 40(1-2):49-61. PubMed ID: 7958064
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of metastatic potential by gamma-interferon.
    Kelly SA, Gschmeissner S, East N, Balkwill FR.
    Cancer Res; 1991 Aug 01; 51(15):4020-7. PubMed ID: 1906780
    [Abstract] [Full Text] [Related]

  • 7. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
    Chen Z, Rosten SI, Lord EM, Gaspari AA.
    Reg Immunol; 1993 Aug 01; 5(5):285-92. PubMed ID: 8148238
    [Abstract] [Full Text] [Related]

  • 8. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
    Yim JH, Wu SJ, Casey MJ, Norton JA, Doherty GM.
    J Immunol; 1997 Feb 01; 158(3):1284-92. PubMed ID: 9013971
    [Abstract] [Full Text] [Related]

  • 9. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 Feb 01; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

  • 10. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB, Cestari S.
    Cell Immunol; 1997 May 25; 178(1):79-90. PubMed ID: 9184701
    [Abstract] [Full Text] [Related]

  • 11. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.
    Weber JS, Rosenberg SA.
    Cancer Res; 1988 Oct 15; 48(20):5818-24. PubMed ID: 3139284
    [Abstract] [Full Text] [Related]

  • 12. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB.
    J Immunol; 1995 May 01; 154(9):4613-22. PubMed ID: 7722313
    [Abstract] [Full Text] [Related]

  • 13. Enhanced cell-mediated cytotoxicity by interferon-gamma and interleukin-2 against syngeneic murine mammary adenocarcinoma.
    Nakajima I, Chu TM.
    Mol Biother; 1992 Mar 01; 4(1):47-52. PubMed ID: 1627274
    [Abstract] [Full Text] [Related]

  • 14. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha.
    Yeoman H, Anderton JG, Stanley MA.
    Immunology; 1989 Jan 01; 66(1):100-5. PubMed ID: 15493270
    [Abstract] [Full Text] [Related]

  • 15. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
    Doukas J, Pober JS.
    J Immunol; 1990 Aug 15; 145(4):1088-98. PubMed ID: 1974272
    [Abstract] [Full Text] [Related]

  • 16. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B.
    Cancer Gene Ther; 2000 Dec 15; 7(12):1543-56. PubMed ID: 11228533
    [Abstract] [Full Text] [Related]

  • 17. Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.
    Burnham DK, Mak CK, Webster RJ, Daynes RA.
    Transplantation; 1989 Mar 15; 47(3):533-42. PubMed ID: 2493701
    [Abstract] [Full Text] [Related]

  • 18. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. I. Effects on class I antigen expression.
    Maudsley DJ, Morris AG.
    Immunology; 1989 May 15; 67(1):21-5. PubMed ID: 2544513
    [Abstract] [Full Text] [Related]

  • 19. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
    Elliott BE, Carlow DA, Ivimey L, Arnold M, Hampton N, Bosman P.
    Cancer Res; 1987 Sep 15; 47(18):4915-23. PubMed ID: 2441856
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.